HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
C M Alexander Selected Research
C M Alexander Research Topics
Disease
5
Type 2 Diabetes Mellitus (MODY)
05/2013 - 04/2007
4
Coronary Disease (Coronary Heart Disease)
03/2008 - 11/2000
2
Carcinogenesis
03/2007 - 07/2000
1
COVID-19
03/2021
1
Diabetes Complications
05/2013
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2008
1
Lymphoma (Lymphomas)
03/2007
1
Neoplasms (Cancer)
03/2007
1
Hypertrophy
02/2001
1
Dyslipidemias (Dyslipidemia)
01/2001
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2001
1
Coronary Artery Disease (Coronary Atherosclerosis)
12/2000
1
Hypertension (High Blood Pressure)
11/2000
1
Diabetes Mellitus
11/2000
1
Hyperlipidemias (Hyperlipidemia)
09/2000
Drug/Important Bio-Agent (IBA)
3
Metformin (Glucophage)
FDA Link
Generic
05/2009 - 04/2007
2
Sitagliptin Phosphate (Januvia)
FDA Link
05/2013 - 11/2010
2
Cholesterol
IBA
03/2008 - 03/2001
2
Syndecan-1 (Syndecan 1)
IBA
03/2007 - 07/2000
2
Simvastatin (Zocor)
FDA Link
Generic
01/2001 - 09/2000
1
Thiazolidinediones
IBA
05/2009
1
2,4-thiazolidinedione (thiazolidinedione)
IBA
06/2008
1
Triglycerides (Triacylglycerol)
IBA
03/2008
1
anthracene
IBA
03/2007
1
Carcinogens
IBA
03/2007
1
oxidized low density lipoprotein
IBA
03/2001
1
LDL Cholesterol
IBA
03/2001
1
Tissue Inhibitor of Metalloproteinase-1
IBA
02/2001
1
Tissue Inhibitor of Metalloproteinases
IBA
02/2001
1
Lovastatin (Mevacor)
FDA Link
Generic
12/2000
1
HDL Cholesterol
IBA
11/2000
1
Glucose (Dextrose)
FDA Link
Generic
11/2000
1
Lipids
IBA
11/2000
1
Proteoglycans (Proteoglycan)
IBA
07/2000
Therapy/Procedure
2
Therapeutics
05/2013 - 05/2009
1
Personal Protective Equipment
03/2021